REQUEST A DEMO
Total
USD $0.00
Search more companies

I.P.S. Centro de Salud Ucata - Charta Santander (Colombia)

Main Activities: Hospitals
Full name: I.P.S. Centro de Salud Ucata - Charta Santander Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

I.P.S. Centro de Salud Ucata - Charta Santander is an enterprise located in Colombia, with the main office in Charta. It operates in the Hospitals industry. It was incorporated on December 18, 2014. In its most recent financial highlights, the company reported a net sales revenue increase of 32.01% in Q2C2024. Its total assets grew by 18.9% over the same period. The net profit margin of I.P.S. Centro de Salud Ucata - Charta Santander increased by 11.17% in 2024.

Headquarters
Carrera 2 2 79
Charta; Santander; Postal Code: 680551

Contact Details: Purchase the I.P.S. Centro de Salud Ucata - Charta Santander report to view the information.

Basic Information
Outstanding Shares:
Purchase the I.P.S. Centro de Salud Ucata - Charta Santander report to view the information.
Incorporation Date:
December 18, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Treasurer
Company Performance
Financial values in the chart are available after I.P.S. Centro de Salud Ucata - Charta Santander report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
32.01%
Total operating revenue
32.01%
Operating profit (EBIT)
101.04%
Net Profit (Loss) for the Period
107.43%
Total assets
18.9%
Total equity
21.76%
Operating Profit Margin (ROS)
10.38%
Net Profit Margin
11.17%
Return on Equity (ROE)
12.69%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?